Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

686
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
686

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia.

Clinical parkinsonism & related disorders·2022
Same author

Medications used to treat tremors.

Journal of the neurological sciences·2022
Same author

Parkinsonism in viral, paraneoplastic, and autoimmune diseases.

Journal of the neurological sciences·2021
Same author

Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool.

Parkinsonism & related disorders·2020
Same author

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease.

Parkinsonism & related disorders·2019
Same author

Setting the record straight: The nosology of tardive syndromes.

Parkinsonism & related disorders·2018
Same journal

Hyperkinetic manifestations in sporadic parkinsonism: An exploratory case series with APOE and NOS3 variants.

Clinical parkinsonism & related disorders·2026
Same journal

Clinical and autonomic correlates of chronic Sialorrhea in Parkinson's disease: a questionnaire-based study with cluster analysis of autonomic and dysphagia burden.

Clinical parkinsonism & related disorders·2026
Same journal

Cerebral hemodynamic changes and their effects on cognitive function in patients with Parkinson's disease complicated with orthostatic hypotension.

Clinical parkinsonism & related disorders·2026
Same journal

Mark Hallett: scientist and humanitarian in modern movement disorder neurology.

Clinical parkinsonism & related disorders·2026
Same journal

Factors influencing receipt of specialty neurologic care for patients with Huntington's disease in Colorado.

Clinical parkinsonism & related disorders·2026
Same journal

Mark Hallett and the renaissance of functional neurological disorder.

Clinical parkinsonism & related disorders·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.3K

Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm.

Deepmala Nandanwar1, Daniel D Truong1

  • 1The Parkinson and Movement Disorder Institute, 9940 Talbert Avenue, Fountain Valley, CA 92708, USA.

Clinical Parkinsonism & Related Disorders
|October 9, 2024
PubMed
Summary
This summary is machine-generated.

Multiple system atrophy (MSA), a synucleinopathy, presents with autonomic dysfunction, parkinsonism, or ataxia. This study proposes a diagnostic algorithm to guide the use of tests like MRI and autonomic testing for MSA diagnosis.

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

31.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Related Experiment Videos

Last Updated: Jun 11, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.3K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

31.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.4K

Area of Science:

  • Neurology
  • Pathology
  • Diagnostic Imaging

Background:

  • Multiple system atrophy (MSA) is a rare, fatal neurodegenerative disorder characterized by autonomic dysfunction, parkinsonism, and cerebellar ataxia.
  • MSA shares pathological features with Parkinson's disease (PD) and Lewy body dementia (DLB), collectively termed synucleinopathies.
  • Alpha-synuclein glial cytoplasmic inclusions are the pathological hallmark of MSA, detectable in skin biopsies.

Purpose of the Study:

  • To propose a diagnostic algorithm for Multiple System Atrophy (MSA).
  • To clarify the appropriate utilization of diagnostic tests in MSA evaluation.
  • To aid clinicians in differentiating MSA from other neurological conditions.

Main Methods:

  • Review of current diagnostic tools for MSA, including brain MRI, cardiac MIBG scans, autonomic function tests, and urodynamic studies.
  • Development of a diagnostic algorithm to guide the sequential or parallel use of these investigations.
  • Comparison of the proposed algorithm with existing Movement Disorder Society (MDS) diagnostic criteria for MSA.

Main Results:

  • Brain MRI findings such as the "Hot-cross bun" sign, putaminal atrophy, and infratentorial abnormalities can support MSA diagnosis.
  • Specific tests like cardiac MIBG scans, autonomic testing, and urodynamic studies are crucial for differentiating MSA from other disorders.
  • The proposed algorithm provides a structured approach to diagnostic testing in suspected MSA cases.

Conclusions:

  • Diagnostic tools are available for MSA, but their optimal application requires clear guidance.
  • The suggested algorithm aims to enhance the diagnostic process for MSA, complementing existing criteria.
  • Further refinement and validation of the diagnostic algorithm may improve early and accurate MSA diagnosis.